MiRNA expression and functions in glioma and glioma stem cells

Chaya Brodie, Efrat Buchris, Hae Kyung Lee

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Scopus citations

Abstract

Glioblastoma (GBMs) are the most common and aggressive primary brain tumors. Current treatments include surgery, radiation therapy, and chemotherapy. Unfortunately, prognosis remains extremely poor and the median survival of 12-14 months in GBM has not changed significantly. GBMs contain a small subpopulation of glioma stem cells (GSCs) that are implicated in therapeutic resistance and tumor recurrence. Thus, the development of new therapeutic strategies to target these cells is of utmost significance. MicroRNAs (miRNAs) have been reported to play a major role in cancer development and progression and are now emerge as potential therapeutic targets in various tumors. This chapter reviews the expression of miRNAs in GBM and GSCs and their use as diagnostic and prognostic biomarkers and discusses the role of specific miRNAs in GSC functions and their potential use as therapeutic targets. Since the clinical use of miRNAs is hindered by lack of effective delivery mechanisms to tumor sites, a particular focus is placed on the possible modes of delivery of miRNA mimics or antagonists focusing on viral vectors, nanoparticles, exosomes and stem cells.

Original languageEnglish
Title of host publicationMicroRNA Targeted Cancer Therapy
PublisherSpringer International Publishing
Pages29-49
Number of pages21
ISBN (Electronic)9783319051345
ISBN (Print)3319051334, 9783319051338
DOIs
StatePublished - 1 Feb 2014

Bibliographical note

Publisher Copyright:
© Springer International Publishing Switzerland 2014. All rights reserved.

Fingerprint

Dive into the research topics of 'MiRNA expression and functions in glioma and glioma stem cells'. Together they form a unique fingerprint.

Cite this